Brief: Astellas And Taysha Gene Therapies Announce Strategic Investment To Support Development Of Taysha's AAV-Based Gene Therapy Programs

Taysha Gene Therapies

25/10/2022 24:34

Oct 24 (Reuters) - Taysha Gene Therapies Inc  TSHA.O :
    * ASTELLAS AND TAYSHA GENE THERAPIES ANNOUNCE STRATEGIC
INVESTMENT
TO SUPPORT DEVELOPMENT OF TAYSHA'S AAV-BASED GENE THERAPY
PROGRAMS
    * ASTELLAS - WILL INVEST A TOTAL OF $50 MILLION TO ACQUIRE
15% OF
OUTSTANDING COMMON STOCK OF TAYSHA
    * ASTELLAS - ASTELLAS TO RECEIVE CERTAIN RIGHTS RELATED TO
ANY
POTENTIAL CHANGE OF CONTROL OF TAYSHA
    * ASTELLAS - ASTELLAS TO RECEIVE ONE BOARD OBSERVER SEAT ON
THE
TAYSHA BOARD OF DIRECTORS

Source text for Eikon:  ID:nPn2z0LB3a 
Further company coverage:  TSHA.O 
 ((Reuters.Briefs@thomsonreuters.com;))